Copper strategy weakens drug-resistant bacteria and cancer cells

University of Missouri scientists have identified a novel mechanism by which the body’s natural copper‑based defenses can be harnessed. Copper, an essential trace element that fuels key metabolic reactions, becomes harmful when its levels rise too high. Cells normally keep copper in check through a network of specialized proteins that direct its transport and storage.

The new study reveals how one of these regulatory proteins can be leveraged to boost copper’s protective functions without triggering toxicity. By fine‑tuning the protein’s activity, the researchers demonstrated a controlled increase in copper‑mediated antimicrobial and antioxidant responses. This approach could offer a new strategy for treating conditions linked to copper imbalance, such as Wilson’s disease or neurodegenerative disorders, where precise regulation of the metal is critical.

The findings highlight the delicate balance of copper homeostasis in human biology and suggest that targeted manipulation of copper‑transport proteins may become a therapeutic tool. Further research will be needed to translate this mechanism into clinical applications, but the discovery opens a promising avenue for exploiting copper’s dual role as both a vital nutrient and a potent defense agent.